November 2007

Venture Capital Returns

November 30, 2007

At a recent event was recently asked about investment outcomes for venture capitalists. I didn’t have any recent data, so I said that VCs generally expect that 1/3 of their investments will see great returns, 1/3 will see modest or no returns, and 1/3 will not be profitable. VC Fred Wilson as Union Square Ventures [...]

Read the full article →

Call for Papers: Biotechnology Marketing

November 29, 2007

Journal of Commercial Biotechnology – Special Issue on Product Innovation Management and Marketing Focus of the Special Issue Biotechnology companies are product innovation firms, yet they face a collection of challenges which make it inappropriate to simply apply existing innovation management thinking. For instance, at present relatively few biotechnology firms generate earned income from sales. [...]

Read the full article →

Career Development in Biotechnology

November 16, 2007

I’ll be giving a talk on “Career Development in Biotechnology” next week in the AstraZeneca seminar series at the University of Toronto. More details are available at the MBiotech website.

Read the full article →

Rethink PCR

November 6, 2007

Bio-Rad’s got an interesting website up: RethinkPCR. The company’s name isn’t posted on the front page, but is readily available in the contest terms and conditions and privacy policy. It’s an interesting strategy to acquire consumer intelligence. Of course, consumers don’t always ask for what they want — they tend to ask for incremental improvements [...]

Read the full article →

Drug Patent Expirations in November 2007

November 1, 2007

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in November 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration ANDRODERM Watson Labs testosterone 4,849,224 NOV 12,2007 ANDRODERM Watson Labs testosterone 4,983,395 NOV 12,2007 AVITA Mylan Bertek tretinoin 4,971,800 NOV 20,2007 COMTAN Orion entacapone 4,963,590 NOV 27,2007 ELOCON Schering mometasone [...]

Read the full article →